Sponsorship verdict
Sponsorship possible
One solid signal, not two. Worth applying, and worth asking about sponsorship early.
-
✓
Employer is on a government sponsor recordThe US Department of Labor certified 99 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first.
-
?
The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
-
?
No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area.
-
✓
What Astrazeneca Pharmaceuticals Lp paid sponsored hires in similar roles15 certified filings for “Associate Director Oncology Outcomes Research” (Medical Scientists, Except Epidemiologists) in MD: $126k–$185k, median $140k.
-
✓
Confirmed live todayWhen a source last listed this job as open.
Details and sources
- Employer is on a government sponsor record
- The US Department of Labor certified 99 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. Source: LCA disclosure data (US Department of Labor (OFLC)).
- No salary bar for this route
- H-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Astrazeneca Pharmaceuticals Lp paid sponsored hires in similar roles
- 15 certified filings for “Associate Director Oncology Outcomes Research” (Medical Scientists, Except Epidemiologists) in MD: $126k–$185k, median $140k. Most were filed at wage level II (47%) — 2 lottery entries, ≈31% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence. It is not legal advice and never a guarantee: the employer and the immigration authority decide. Sign in to factor in where you can already work.
About the role
Location: Wilmington, Delaware
Hybrid: 3 days a week onsite
The Senior Director, US Scientific Communications sets the strategic agenda for the US medical communications function. They are accountable for building and evolving a high-performing team that defines the overall US medical content development strategy. They improve the quality, reach, and impact of scientific communications deliverables. They also deliver on license to operate work, including Medical Information activities and US Promotional review.
This role reports to the Head of US Medical Excellence, and partners closely with the core functions under the US Medical Excellence team, US Medical Affairs and US Commercial Brand and Therapy Areas teams, Global Scientific Communications, Promotional Regulatory Affairs, Legal, Compliance, Global Business Services (GBS), enterprise digital teams, and external agencies or platform partners.
Typical Accountabilities:
Strategic Leadership and Operating Model
• Set the long-term vision, priorities, and transformation agenda for US Scientific Communications, ensuring the function drives scientific narrative pull-through, strategic impact, and measurable value across US BBU
• Define and direct the American medical content strategy. Improve the global-to-local process to better prioritize, reuse, govern, and deliver high-impact scientific content.
• Evolve and lead the current operating model supporting Medical Information and promotional review activities, identifying and implementing opportunities to enhance efficiency, quality, and collaborator experience while maintaining regulatory compliance.
• Content excellence and performance: Establish standards, critical metrics, and feedback loops that elevate quality, speed, accessibility, discoverability, compliance, and measurable content impact.
• Innovation and AI-enabled transformation: Champion future-ready approaches, including agentic AI and automation, to modernize content creation, review, delivery, and workflow design.
• Future-ready operating model: Build and evolve a modern SciComms operating model that integrates license-to-operate responsibilities with scalable content strategy, agile ways of working, and continuous improvement.
Enterprise Collaboration
• US Medical and TA collaboration: Work closely with US Medical, TA, and Commercial leaders to align SciComms priorities with Medical Plans, brand needs, key achievements, and business objectives.
• Global Scientific Communications partnership: Partner with Global SciComms to improve content pull-through while ensuring US insights, market needs, customer trends, and performance metrics shape global planning.
• Enterprise thought leadership: Serve as a strategic enterprise partner, bringing SciComms expertise, innovation, and best practices into broader US business priorities.
• GBS and internal partner leadership: Coordinate both GBS and in-house delivery teamworks to ensure clear service build, sourcing, demand management, quality oversight, and handling of blocking issues.
Team Management and Resources
• Resource and milestone readiness: Plan and manage resources to support TA priorities and ensure readiness for launches, data readouts, congresses, and other critical business moments.
• Financial and vendor stewardship: Lead budget planning and oversee agency, third-party, and vendor investments to ensure spend is strategically allocated and tied to measurable value.
• Talent and capability development: Build, mentor, and develop a high-performing SciComms team, advancing capabilities in content strategy, innovation, operational excellence, and enterprise partnership.
Essential Requirements:
• Advanced degree in scientific discipline or applicable health sciences field (PharmD, PhD, MD)
Apply on employer site ↗